Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Should we buy more???
View:
Post by fundtrader on Aug 29, 2016 12:19pm

Should we buy more???

whenever i turn my desk on, the value that cxr offers to new investors is just amazing. APPROX 50 MILLION shares outstanding . 30% of float or 13 million shares need to be covered. Strateguc review close to completion with a poteintial double or a triple. I guess buying this at 100$ us was stupid but under 10$ is a deal of a lifetime. Almost 500 million + in ebidita in 2016 and 145 million $ in cash. + 60 new products to be launched shortly with over 200 + other products on sale in 100 countries..mind boggling but i think new management could do wonders here...
Comment by Marky1 on Aug 29, 2016 12:43pm
Funtrader...couldn't agree with you more! A real fire sale!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities